References to full-text articles available online...
This page provides an alphabetical list of references to research articles from this site that have a full-text version available online. Also see Diabetes Books & Articles. To find research articles, search PubMed, AJCN, NEJM, JAMA, BMJ, ACP-Annals, or Diabetes Care
  1. 1998 Clinical Practice Guidelines for the Management of Diabetes in Canada, CMAJ, October 20, 1998
  2. Ontario's Chief Medical Officer of Health Report on Strategies for Preventing Diabetes, 10 November 1999
  3. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Diabetes Care, Volume 25, Supplement 1, ADA Clinical Practice Recommendations 2002
  4. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update, Circulation, 2002;106:388
  5. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association, Circulation, 2000;102:2284
  6. AHA Dietary Protein and Weight Reduction
  7. AMA Coordinated Performance Measurement for the Management of Adult Diabetes, April 2001
  8. Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus, NEJM Vol 342:1392-1398 May 11, 2000 Number 1
  9. Carbohydrates in Human Nutrition, FAO/WHO Joint Report, April 1997
  10. Cholesterol-lowering Effects of Dietary Fiber, AJCN, Vol. 69, No. 1, pages 30-42, January 1999
  11. A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure, NEJM Vol 336:1117-1124, Apr 17, 1997
  12. Diabetes and the Risk of Pancreatic Cancer, NEJM Vol 331:81-84, Jul 14, 1994
  13. Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus, NEJM Vol 333:541-549, Aug 31, 1995
  14. Effect on Blood Lipids of Very High Intakes of Fiber in Diets Low in Saturated Fat and Cholesterol, NEJM Vol 329:21-26, Jul 1, 1993
  15. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus, NEJM Vol 324:78-84, Jan 10, 1991
  16. Effects of Different Forms of Dietary Hydrogenated Fats on Serum Lipoprotein Cholesterol Levels, NEJM Vol 340:1933-1940, Jun 24, 1999
  17. Endocrinology Pathophysiology, Colorado State University, Biomedical Hypertextbook
  18. Frequency of blood glucose monitoring in relation to glycaemic control, BMJ Vol. 319, 8386 July 10, 1999
  19. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition, BMJ Vol. 322, 15 January 6, 2001
  20. Guidelines for the Nutritional Management of Diabetes Mellitus in the New Mellennium, Position Statement, Canadian Diabetes Association
  21. Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus, NEJM Vol 329:1988-1992, Dec 30, 1993
  22. Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids, NEJM Vol 333:276-282, Aug 3, 1995
  23. Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus, NEJM Vol 333:550-554 August 31, 1995 Number 9
  24. Natural History of Peripheral Neuropathy in Patients with Non-Insulin-Dependent Diabetes Mellitus, NEJM Vol 333:89-94, Jul 13, 1995
  25. Slow and fast dietary proteins differently modulate postprandial protein accretion, Proc. Natl. Acad. Sci. USA: Vol. 94, No. 26, 14930-14935, December 23, 1997
  26. UKPDS UK Prospective Diabetes Study Summary: Results of 20-year trial with 5102 people with Type 2 Diabetes
  27. UKPDS35: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes , BMJ Vol. 321, 405-412 August 12, 2000. Summary: 1% reduction in HbA1c = 21% reduction in risks
  28. UKPDS38: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, BMJ 1998; 317:703-713, 12 September
  29. Effects of silibinin and antioxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cell cultures; Wenzel S, Stolte H, Soose M.; J Pharmacol Exp Ther 1996 Dec;279(3):1520-6
  30. Effects of silybin on red blood cell sorbitol and nerve conduction velocity in diabetic patients [Chinese original]; JQ Zhang, et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 1993 Dec;13(12):725-6, 708
  31. Endogenous mono-ADP-ribosylation in retina and peripheral nervous system. Effects of diabetes; A Gorio, et al; Adv Exp Med Biol 1997;419:289-95
  32. Silymarin inhibits the development of diet-induced hypercholesterolemia in rats; V Krecman, et al; Planta Med 1998 Mar;64(2):138-42
  33. The effect of bioflavonoids and lecithin on the course of experimental atherosclerosis in rabbits [Polish original]; M Bialecka; Ann Acad Med Stetin 1997;43:41-56
  34. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents; R Agarwal; Biochem Pharmacol 2000 Oct 15;60(8):1051-9
  35. Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review Silvio E Inzucchi, January 16, 2002. JAMA, Vol. 287, page 360
  36. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. KS McCully. Am J Pathol 1969 Jul;56(1):111-28
  37. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans.
    Petra Verhoef, et al. AJCN Vol. 76, No. 6, 1244-1248, December 2002
  38. Homocysteine, Folate, Vitamin B6, and Cardiovascular Disease Kilmer S. McCully, February 4, 1998. JAMA, Vol. 279, page 392
  39. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis, P Verhoef, et al. Arterioscler Thromb Vasc Biol 1997 May;17(5):989-95
  40. Hyperhomocyst(e)inemia and the Increased Risk of Venous Thromboembolism. Loralie J. Langman, et al. AMA Arch Intern Med. 2000;160:961-964
  41. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence, JW Eikelboom, et al. Ann Intern Med 1999 Sep 7;131(5):363-75
  42. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. DG Hackam, JC Peterson, JD Spence. Am J Hypertens 2000 Jan;13(1 Pt 1):105-10
  43. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care, GL Booth, EE Wang, CMAJ 2000 Jul 11;163(1):21-9
  44. Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease Effect of Grain Fortification and Beyond, Jeffrey A. Tice, et al. JAMA. 2001; 286:936-943
  45. Randomized Trial of Folic Acid Supplementation and Serum Homocysteine Levels David S. Wald, et al. March 12, 2001. Archives of Internal Medicine, Vol. 161, page 695
  46. Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus: The Hoorn Study. Ellen K. Hoogeveen, et al, October 23, 2000. Archives of Internal Medicine, Vol.160, page 2984
  47. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. MA Hofmann, et al. Diabetes Care 20: 1880-1886
  48. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. YM Smulders, et al. Diabetes Care 1999 22: 125-132
  49. Fasting Plasma Homocysteine Levels in the Insulin Resistance Syndrome: The Framingham Offspring Study. James B. Meigs, et al. Diabetes Care 2001 24: 1403-1410
  50. The Relationship Among Homocysteine, Creatinine Clearance, and Albuminuria in Patients With Type 2 Diabetes. Linda Davies, et al. Diabetes Care 2001 24: 1805-1809.
  51. Impact of Insulin Resistance and Nephropathy on Homocysteine in Type 2 Diabetes. Masanori Emoto, et al. Diabetes Care 2001 24: 533-538.
  52. Homocysteine and cardiovascular disease in diabetes mellitus, MC Audelin, J Genest Jr, Atherosclerosis 2001 Dec;159(2):497-511
  53. Whole Grain Consumption and Risk of Ischemic Stroke in Women: A Prospective Study Simin Liu, et al. September 27, 2000. JAMA, Vol. 284, page 1534
  54. Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial, Thomas A. Barringer, et al, Annals of Internal Medicine, 4 March 2003 Vol. 138 No. 5, pp. 365–371
  55. The influence of dietary protein on tissue glutathione and the diseases of aging, G Bounous, F Gervais, V Amer, G Batist, P Gold, 1989. Clinical Investigative Medicine, 12, 6:343
  56. The biological activity of undenatured dietary whey proteins: role of glutathione, G Bounous, P Gold, 1991. Clinical Investigative Medicine, 14(4):296-309
  57. Immunoenhancing property of dietary whey protein in mice: role of glutathione, G Bounous, et al, 1989. Clinical Investigative Medicine, 12:154-161
  58. Competition for glutathione precursors between the immune system and the skeletal muscle: Pathogenesis of chronic fatigue syndrome, G Bounous, J Molson, 1999. Medical Hypothesis, 53(4):347-349.
  59. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment, G Bounous, Anticancer Res 2000 Nov-Dec; 20(6C):4785-92
  60. Whey Proteins in cancer prevention, G Bounous, G Batist, P Gold, Cancer Lett 1991 May 1;57(2):91-4
  61. Whey proteins as a food supplement in HIV-seropositive individuals, G Bounous, S Baruchel, J Falutz, P Gold, Clin Invest Med 1993 Jun;16(3):204-9
  62. Oral supplementation with whey proteins increases plasma glutathione levels of HIV infected patients, M Beeh, et al, 2001. European Journal of Clinical Investigation, February, 31(2):171- 178
  63. Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects, CR Markus, B Olivier, EH de Haan, AJCN 2002 Jun;75(6):1051-6
  64. The effects of protein intake on blood pressure and cardiovascular disease, LJ Appel, Curr Opin Lipidol 2003 Feb;14(1):55-9
  65. Slow and fast dietary proteins differently modulate post-prandial protein accretion, Y Boirie, et al., 1997. Proceedings of the National Academy of Sciences, 94:14930-14935.
  66. Protein Controversies in Diabetes, Marion J Franz. Diabetes Spectrum, Vol. 13, No. 3, 2000, 132-141
  67. Effect of Protein Ingestion on the Glucose Appearance Rate in People with Type 2 Diabetes, MC Gannon, JA Nuttall, G Damberg, V Gupta, FQ Nuttall, Journal of Clinical Endocrinology & Metabolism, Vol. 86, March 2001, 1040-1047
  68. A Double blind comparative pilot trial evaluating the effect of whey protein isolate and isolated soy protein in healthy adults. LA Nelson, CM Colker, DS Kalman, and M Swain. February 2002. Divisco funded study.
  69. Interaction of glucose and long chain fatty acids (C18) on antioxidant defences and free radical damage in porcine vascular smooth muscle cells in vitro, JS Hamilton, et al, Diabetologia 2003 Jan;46(1):106-14
  70. Importance of glycemic index in diabetes, JC Miller, AJCN, Vol 59, 747S-752S,1994.
  71. C-reactive protein and diabetes mellitus type 2: The Hoorn Study, MB Snijder, JM Dekker, et al
  72. Relation of Impaired Fasting and Postload Glucose With Incident Type 2 Diabetes in a Dutch Population: The Hoorn Study, Femmie de Vegt, Jacqueline M Dekker, et al, JAMA. 2001;285:2109-2113
  73. C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus, Aruna D Pradhan, JoAnn E Manson, Nader Rifai, Julie E Buring, & Paul M Ridker, JAMA Vol. 286, No. 3, pp. 327-334, July 18 2001
  74. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women, Simin Liu, JoAnn E Manson, Julie E Buring, Meir J Stampfer, Walter C Willett & Paul M Ridker, AJCN, Vol. 75, No. 3, 492-498, March 2002.
  75. Glycemic index, glycemic load, and risk of type 2 diabetes, Walter Willett, JoAnn Manson and Simin Liu, AJCN, Vol. 76, No. 1, 274S-280S, July 2002.
  76. International table of glycemic index and glycemic load values: 2002, Kaye Foster-Powell, Susanna HA Holt, and Janette C Brand-Miller, AJCN, Vol.76, No.1, 5-56, July 2002
  77. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events, Paul M Ridker, Nader Rifai, Lynda Rose, Julie E Buring, & Nancy R Cook, NEJM, Vol. 347:1557-1565, No. 20, November 14 2002
  78. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance, Thomas MS Wolever and Christine Mehling, AJCN, Vol. 77, No. 3, 612-621, March 2003
  79. ADA Clinical Practice Recommendations 2003, Diabetes Care, Vol. 26, Supplement 1
  80. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance, Marjorie L McCullough, Diane Feskanich, Meir J Stampfer, Edward L Giovannucci, Eric B Rimm, Frank B Hu, Donna Spiegelman, David J Hunter, Graham A Colditz and Walter C Willett, AJCN, Vol. 76, No. 6, 1261-1271, December 2002
  81. The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency, E.L. Knight, M.J. Stampfer, S.E. Hankinson, D. Spiegelman, and G.C. Curhan, Annals of Internal Medicine, 18 March 2003, Volume 138, Number 6, pages 460–467
  82. Banting lecture 1988. Role of insulin resistance in human disease, G.M. Reaven, Diabetes, Vol 37, Issue 12 1595-1607
  83. The Prevention or Delay of Type 2 Diabetes, Diabetes Care 26:S62-S69, 2003
  84. Diabetes Facts and Misconceptions, IDF
  85. United Nations Resolution 61/225 World Diabetes Day, December 20 2006

Updated: May 21, 2007